Nurexone Biologic Inc
OTC:NRXBF
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Nurexone Biologic Inc
OTC:NRXBF
|
CA |
|
C
|
CenterPoint Energy Inc
F:HOU
|
US |
|
C
|
CAC Holdings Corp
F:CB4
|
JP |
|
Lipocine Inc
NASDAQ:LPCN
|
US |
|
Comcast Corp
NASDAQ:CMCSA
|
US |
|
H
|
HeidelbergCement AG
XHAM:HEI
|
DE |
|
H
|
Hollysys Automation Technologies Ltd
LSE:0M58
|
CN |
|
M
|
Mosaic Co
F:02M
|
US |
|
B
|
Bank Negara Indonesia (Persero) Tbk PT
SWB:BKE1
|
ID |
|
C
|
Comcast Corp
XBER:CTP2
|
US |
|
S
|
Stroeer SE & Co KgaA
XHAM:SAX
|
DE |
|
N
|
Novozymes A/S
F:NZM2
|
DK |
|
P
|
Paycom Software Inc
F:0PY
|
US |
|
Sinopec Oilfield Service Corp
OTC:YZCFF
|
CN |
|
S
|
Sinopec Oilfield Service Corp
XMUN:YIZH
|
CN |
|
L
|
Landstar System Inc
SWB:LDS
|
US |
|
R
|
Rio Tinto PLC
F:RIO1
|
UK |
Wall St Price Targets
NRXBF Price Targets Summary
Nurexone Biologic Inc
According to Wall Street analysts, the average 1-year price target for
NRXBF is 3.0153 USD with a low forecast of 2.9857 USD and a high forecast of 3.104 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NRXBF's stock price target?
Price Target
3.0153
USD
According to Wall Street analysts, the average 1-year price target for
NRXBF is 3.0153 USD with a low forecast of 2.9857 USD and a high forecast of 3.104 USD.